BNP PARIBAS FINANCIAL MARKETS - NYMOX PHARMACEUTICAL CORP ownership

NYMOX PHARMACEUTICAL CORP's ticker is NYMX and the CUSIP is P73398102. A total of 65 filers reported holding NYMOX PHARMACEUTICAL CORP in Q3 2020. The put-call ratio across all filers is 1.70 and the average weighting 0.0%.

Quarter-by-quarter ownership
BNP PARIBAS FINANCIAL MARKETS ownership history of NYMOX PHARMACEUTICAL CORP
ValueSharesWeighting
Q2 2023$163
-44.2%
8590.0%0.00%
Q1 2023$292
-24.9%
859
-28.6%
0.00%
Q4 2022$389
-99.9%
1,2030.0%0.00%
Q3 2022$499,000
-28.3%
1,203
-24.8%
0.00%
Q2 2022$696,000
-67.5%
1,600
-5.9%
0.00%
Q1 2022$2,142,000
-3.1%
1,7000.0%0.00%
Q4 2021$2,210,000
-36.8%
1,700
+0.2%
0.00%
Q3 2021$3,496,000
+0.7%
1,697
-22.8%
0.00%
Q2 2021$3,471,000
-74.6%
2,197
-64.2%
0.00%
Q1 2021$13,640,000
-14.0%
6,144
-4.0%
0.00%
Q4 2020$15,867,000
-29.0%
6,398
-29.5%
0.00%
Q3 2020$22,339,000
+322.6%
9,081
+509.9%
0.00%
Q2 2020$5,286,000
+1120.8%
1,489
+704.9%
0.00%
Q1 2020$433,000
+6.4%
1850.0%0.00%
Q4 2019$407,000
-93.9%
185
-94.9%
0.00%
Q3 2019$6,725,000
+26.9%
3,6550.0%0.00%
Q2 2019$5,300,000
-60.6%
3,655
-46.5%
0.00%
Q1 2019$13,463,000
+1136.3%
6,834
+722.4%
0.00%
Q4 2018$1,089,000
-78.5%
831
-59.6%
0.00%
Q3 2018$5,060,000
-4.5%
2,057
+30.4%
0.00%
Q2 2018$5,299,000
-84.1%
1,577
-79.9%
0.00%
Q1 2018$33,231,000
+25.1%
7,856
-2.4%
0.00%
Q4 2017$26,572,000
+150.0%
8,052
+189.4%
0.00%
Q3 2017$10,627,000
-19.2%
2,782
-6.9%
0.00%
Q2 2017$13,147,0002,9880.00%
Other shareholders
NYMOX PHARMACEUTICAL CORP shareholders Q3 2020
NameSharesValueWeighting ↓
First Citizens Financial Corp 35,100$44,0000.03%
Brown Advisory Securities, LLC 28,000$35,0000.02%
Murchinson Ltd. 76,404$96,0000.02%
WEBSTER BANK, N. A. 80,000$101,0000.01%
Patriot Financial Group Insurance Agency, LLC 34,650$44,0000.01%
WMS Partners, LLC 42,000$53,0000.01%
Willow Creek Wealth Management Inc. 18,724$24,0000.01%
Cubic Asset Management, LLC 14,000$18,0000.00%
CVI Holdings, LLC 45,993$58,0000.00%
One Day In July LLC 10,000$13,0000.00%
View complete list of NYMOX PHARMACEUTICAL CORP shareholders